Hepatitis B virus reactivation with chemotherapy: diagnosis and prevention with antiviral prophylaxis

Affiliations

Comment

Emmet B Keeffe. Rev Gastroenterol Disord. 2004 Winter.

. 2004 Winter;4(1):46-8.

¹ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.

No abstract available

Comment on

Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu CH, Tien HF, Chao TY, Chen LT, Whang-Peng J; Lymphoma Committee of Taiwan Cooperative Oncology Group. Cheng AL, et al. Hepatology. 2003 Jun;37(6):1320-8. doi: 10.1053/jhep.2003.50220. Hepatology. 2003. PMID: 12774010 Clinical Trial.
Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
Yeo W, Chan PK, Hui P, Ho WM, Lam KC, Kwan WH, Zhong S, Johnson PJ. Yeo W, et al. J Med Virol. 2003 Aug;70(4):553-61. doi: 10.1002/jmv.10430. J Med Virol. 2003. PMID: 12794717